BRIDGEMAKER GMBH
Desconocido
SilkPlatelet: Closing the European gap towards a large scale ex vivo platelet production built upon a silk-based s...
BRIDGEMAKER GMBH
participó en un
HORIZON EUROPE:
HORIZON-EIC-2021-TRANSITION-CHALLENGES-01
The generation of ex vivo functional megakaryocytes (MK) and platelets is questioning current transfusion medicine exclusive reliance on blo...
2022-07-25 - 2025-09-30 | Financiado
2022-07-25 - 2025-09-30 | Financiado
* No se disponen de datos de la empresa actual.